Suppr超能文献

DYT1 型肌张力障碍细胞模型中的转录组和蛋白质组分析。

Transcriptional and proteomic profiling in a cellular model of DYT1 dystonia.

机构信息

Graduate Program in Genetics, The University of Iowa, Iowa City, IA, USA.

出版信息

Neuroscience. 2009 Dec 1;164(2):563-72. doi: 10.1016/j.neuroscience.2009.07.068. Epub 2009 Aug 6.

Abstract

DYT1, the most common inherited dystonia, is caused by a common dominant mutation in the TOR1A gene that leads to a glutamic acid deletion in the protein torsinA. Wild-type torsinA locates preferentially in the endoplasmic reticulum while the disease-linked mutant accumulates in the nuclear envelope. As a result, it has been proposed that DYT1 pathogenesis could result either from transcriptional dysregulation caused by abnormal interactions of mutant torsinA with nuclear envelope proteins, or from a loss of torsinA function in the endoplasmic reticulum that would impair specific neurobiological pathways. Aiming to determine whether one or both of these potential mechanisms are implicated in DYT1 pathogenesis, we completed unbiased transcriptional and proteomic profiling in well-characterized neural cell lines that inducibly express wild-type or mutant torsinA. These experiments demonstrated that the accumulation of mutant torsinA in the nuclear envelope is not sufficient to cause transcriptional dysregulation. However, we detected expression changes at the protein level that, together with other reports, suggest a potential implication of torsinA on energy metabolism and regulation of the redox state. Furthermore, several proteins identified in this study have been previously linked to other forms of dystonia. In conclusion, our results argue against the hypothesis of transcriptional dysregulation in DYT1 dystonia, suggesting potential alternative pathogenic pathways.

摘要

DYT1,最常见的遗传性肌张力障碍,是由 TOR1A 基因中的一个常见显性突变引起的,导致蛋白 torsinA 中的谷氨酸缺失。野生型 torsinA 优先定位于内质网,而与疾病相关的突变体则在内核膜中积累。因此,有人提出 DYT1 发病机制可能源于突变 torsinA 与核膜蛋白异常相互作用引起的转录失调,也可能源于内质网中 torsinA 功能丧失,从而损害特定的神经生物学途径。为了确定这两种潜在机制是否都与 DYT1 发病机制有关,我们在经过充分表征的神经细胞系中完成了无偏转录组和蛋白质组学分析,这些细胞系可诱导表达野生型或突变型 torsinA。这些实验表明,突变 torsinA 在核膜中的积累不足以导致转录失调。然而,我们在蛋白质水平上检测到了表达变化,这些变化连同其他报告一起,提示 torsinA 可能对能量代谢和氧化还原状态的调节有潜在影响。此外,本研究中鉴定的几种蛋白质以前与其他形式的肌张力障碍有关。总之,我们的结果反对 DYT1 肌张力障碍中存在转录失调的假说,提示存在潜在的替代发病途径。

相似文献

1
Transcriptional and proteomic profiling in a cellular model of DYT1 dystonia.
Neuroscience. 2009 Dec 1;164(2):563-72. doi: 10.1016/j.neuroscience.2009.07.068. Epub 2009 Aug 6.
2
Aberrant cellular behavior of mutant torsinA implicates nuclear envelope dysfunction in DYT1 dystonia.
J Neurosci. 2004 Mar 17;24(11):2593-601. doi: 10.1523/JNEUROSCI.4461-03.2004.
5
Advances in molecular and cell biology of dystonia: Focus on torsinA.
Neurobiol Dis. 2019 Jul;127:233-241. doi: 10.1016/j.nbd.2019.03.007. Epub 2019 Mar 12.
8
Consequences of the DYT1 mutation on torsinA oligomerization and degradation.
Neuroscience. 2008 Dec 2;157(3):588-95. doi: 10.1016/j.neuroscience.2008.09.028. Epub 2008 Sep 27.
10
Silencing primary dystonia: lentiviral-mediated RNA interference therapy for DYT1 dystonia.
J Neurosci. 2005 Nov 9;25(45):10502-9. doi: 10.1523/JNEUROSCI.3016-05.2005.

引用本文的文献

1
Blood-Based Proteomics for Adult-Onset Focal Dystonias.
Ann Neurol. 2024 Jul;96(1):110-120. doi: 10.1002/ana.26929. Epub 2024 Apr 5.
3
Modern approaches for modelling dystonia and Huntington's disease in vitro and in vivo.
Int J Exp Pathol. 2019 Apr;100(2):64-71. doi: 10.1111/iep.12320. Epub 2019 May 15.
4
Structure of the Golgi apparatus is not influenced by a GAG deletion mutation in the dystonia-associated gene Tor1a.
PLoS One. 2018 Nov 7;13(11):e0206123. doi: 10.1371/journal.pone.0206123. eCollection 2018.
5
Mutations in THAP1/DYT6 reveal that diverse dystonia genes disrupt similar neuronal pathways and functions.
PLoS Genet. 2018 Jan 24;14(1):e1007169. doi: 10.1371/journal.pgen.1007169. eCollection 2018 Jan.
8
Decreased dopamine receptor 1 activity and impaired motor-skill transfer in Dyt1 ΔGAG heterozygous knock-in mice.
Behav Brain Res. 2015 Feb 15;279:202-10. doi: 10.1016/j.bbr.2014.11.037. Epub 2014 Nov 29.
9
Current Gaps in the Understanding of the Subcellular Distribution of Exogenous and Endogenous Protein TorsinA.
Tremor Other Hyperkinet Mov (N Y). 2014 Sep 23;4:260. doi: 10.7916/D8JS9NR2. eCollection 2014.
10
Ezrin expression and cell survival regulation in colorectal cancer.
Cell Signal. 2014 May;26(5):868-79. doi: 10.1016/j.cellsig.2014.01.014. Epub 2014 Jan 22.

本文引用的文献

1
Animal models for drug discovery in dystonia.
Expert Opin Drug Discov. 2008 Jan;3(1):83-97. doi: 10.1517/17460441.3.1.83.
2
Consequences of the DYT1 mutation on torsinA oligomerization and degradation.
Neuroscience. 2008 Dec 2;157(3):588-95. doi: 10.1016/j.neuroscience.2008.09.028. Epub 2008 Sep 27.
4
The pathophysiological basis of dystonias.
Nat Rev Neurosci. 2008 Mar;9(3):222-34. doi: 10.1038/nrn2337.
5
siRNA knock-down of mutant torsinA restores processing through secretory pathway in DYT1 dystonia cells.
Hum Mol Genet. 2008 May 15;17(10):1436-45. doi: 10.1093/hmg/ddn032. Epub 2008 Feb 7.
6
The dystonia-associated protein torsinA modulates synaptic vesicle recycling.
J Biol Chem. 2008 Mar 21;283(12):7568-79. doi: 10.1074/jbc.M704097200. Epub 2007 Dec 31.
7
The inner nuclear envelope as a transcription factor resting place.
EMBO Rep. 2007 Oct;8(10):914-9. doi: 10.1038/sj.embor.7401075.
8
Dopamine release is impaired in a mouse model of DYT1 dystonia.
J Neurochem. 2007 Aug;102(3):783-8. doi: 10.1111/j.1471-4159.2007.04590.x. Epub 2007 Apr 30.
9
Mutant torsinA interferes with protein processing through the secretory pathway in DYT1 dystonia cells.
Proc Natl Acad Sci U S A. 2007 Apr 24;104(17):7271-6. doi: 10.1073/pnas.0701185104. Epub 2007 Apr 11.
10
The inherited dystonias.
Semin Neurol. 2007 Apr;27(2):151-8. doi: 10.1055/s-2007-971170.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验